These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 31678081)
1. Fos expression induced by olanzapine and risperidone in the central extended amygdala. Pinna A; Costa G; Contu L; Morelli M Eur J Pharmacol; 2019 Dec; 865():172764. PubMed ID: 31678081 [TBL] [Abstract][Full Text] [Related]
2. Differential induction of Fos-like-immunoreactivity in the extended amygdala after haloperidol and clozapine. Pinna A; Morelli M Neuropsychopharmacology; 1999 Jul; 21(1):93-100. PubMed ID: 10379523 [TBL] [Abstract][Full Text] [Related]
3. Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine. Fujimura M; Hashimoto K; Yamagami K Eur J Pharmacol; 2000 Jun; 398(1):1-10. PubMed ID: 10856442 [TBL] [Abstract][Full Text] [Related]
4. The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone. Fujimura M; Hashimoto K; Yamagami K Life Sci; 2000 Oct; 67(23):2865-72. PubMed ID: 11106001 [TBL] [Abstract][Full Text] [Related]
5. Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs. Cohen BM; Cherkerzian S; Ma J; Ye N; Wager C; Lange N Psychopharmacology (Berl); 2003 Jun; 167(4):403-10. PubMed ID: 12709776 [TBL] [Abstract][Full Text] [Related]
6. Olanzapine-induced Fos expression in the rat forebrain; cross-tolerance with haloperidol and clozapine. Sebens JB; Koch T; Ter Horst GJ; Korf J Eur J Pharmacol; 1998 Jul; 353(1):13-21. PubMed ID: 9721035 [TBL] [Abstract][Full Text] [Related]
7. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain. Wan W; Ennulat DJ; Cohen BM Brain Res; 1995 Aug; 688(1-2):95-104. PubMed ID: 8542328 [TBL] [Abstract][Full Text] [Related]
8. Different antipsychotics elicit different effects on magnocellular oxytocinergic and vasopressinergic neurons as revealed by Fos immunohistochemistry. Kiss A; Bundzikova J; Pirnik Z; Mikkelsen JD J Neurosci Res; 2010 Feb; 88(3):677-85. PubMed ID: 19774673 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism. Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA J Pharmacol Exp Ther; 2000 Apr; 293(1):8-14. PubMed ID: 10734147 [TBL] [Abstract][Full Text] [Related]
10. Induction of Fos-like-immunoreactivity in the central extended amygdala by antidepressant drugs. Morelli M; Pinna A; Ruiu S; Del Zompo M Synapse; 1999 Jan; 31(1):1-4. PubMed ID: 10025677 [TBL] [Abstract][Full Text] [Related]
11. Effects of olanzapine on regional C-Fos expression in rat forebrain. Robertson GS; Fibiger HC Neuropsychopharmacology; 1996 Feb; 14(2):105-110. PubMed ID: 8822533 [TBL] [Abstract][Full Text] [Related]
12. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs. Atkins JB; Chlan-Fourney J; Nye HE; Hiroi N; Carlezon WA; Nestler EJ Synapse; 1999 Aug; 33(2):118-28. PubMed ID: 10400890 [TBL] [Abstract][Full Text] [Related]
13. Neuroanatomical substrates of the disruptive effect of olanzapine on rat maternal behavior as revealed by c-Fos immunoreactivity. Zhao C; Li M Pharmacol Biochem Behav; 2012 Dec; 103(2):174-80. PubMed ID: 22960130 [TBL] [Abstract][Full Text] [Related]
14. Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain. Oka T; Hamamura T; Lee Y; Miyata S; Habara T; Endo S; Taoka H; Kuroda S Life Sci; 2004 Nov; 76(2):225-37. PubMed ID: 15519367 [TBL] [Abstract][Full Text] [Related]
15. Afferent connections of the interstitial nucleus of the posterior limb of the anterior commissure and adjacent amygdalostriatal transition area in the rat. Shammah-Lagnado SJ; Alheid GF; Heimer L Neuroscience; 1999; 94(4):1097-123. PubMed ID: 10625051 [TBL] [Abstract][Full Text] [Related]
16. Activation of midline thalamic nuclei by antipsychotic drugs. Cohen BM; Wan W; Froimowitz MP; Ennulat DJ; Cherkerzian S; Konieczna H Psychopharmacology (Berl); 1998 Jan; 135(1):37-43. PubMed ID: 9489932 [TBL] [Abstract][Full Text] [Related]
17. The putative atypical antipsychotic drug amperozide preferentially increases c-fos expression in rat medial prefrontal cortex and lateral septum. Nomikos GG; Tham CS; Fibiger HC; Svensson TH Neuropsychopharmacology; 1997 Sep; 17(3):197-201. PubMed ID: 9272486 [TBL] [Abstract][Full Text] [Related]
18. Novel pharmacological approaches to the treatment of schizophrenia. Fink-Jensen A Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983 [TBL] [Abstract][Full Text] [Related]
19. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Deutch AY; Duman RS Neuroscience; 1996 Jan; 70(2):377-89. PubMed ID: 8848147 [TBL] [Abstract][Full Text] [Related]
20. Effect of CFMTI, an allosteric metabotropic glutamate receptor 1 antagonist with antipsychotic activity, on Fos expression in regions of the brain related to schizophrenia. Suzuki G; Satow A; Ohta H Neuroscience; 2010 Jul; 168(3):787-96. PubMed ID: 20399255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]